Novel anti-Plasmodial hits identified by virtual screening of the ZINC database

Abstract Increased resistance of Plasmodium falciparum to most available drugs challenges the control of malaria. Studies with protease inhibitors have suggested important roles for the falcipain family of cysteine proteases. These enzymes act in concert with other proteases to hydrolyze host erythrocyte hemoglobin in the parasite food vacuole. In order to find potential new antimalarial drugs, we screened in silico the ZINC database using two different protocols involving structure- and ligand-based methodologies. Our search identified 19 novel low micromolar inhibitors of cultured chloroquine resistant P. falciparum. The most active compound presented an IC50 value of 0.5 μM against cultured parasites and it also inhibited the cysteine protease falcipain-2 (IC50 = 25.5 μM). These results identify novel classes of antimalarials that are structurally different from those currently in use and which can be further derivatized to deliver leads suitable for optimisation.

[1]  P. Rosenthal,et al.  Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. , 1993, The Journal of clinical investigation.

[2]  Honglin Li,et al.  Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening. , 2009, Journal of medicinal chemistry.

[3]  Philip J. Rosenthal,et al.  Antimalarial Activities of Novel Synthetic Cysteine Protease Inhibitors , 2003, Antimicrobial Agents and Chemotherapy.

[4]  Mitchell A. Avery,et al.  Identification of Novel Malarial Cysteine Protease Inhibitors Using Structure-Based Virtual Screening of a Focused Cysteine Protease Inhibitor Library , 2011, J. Chem. Inf. Model..

[5]  William R. Roush,et al.  Structure-Activity Relationships for Inhibition of Cysteine Protease Activity and Development of Plasmodium falciparum by Peptidyl Vinyl Sulfones , 2003, Antimicrobial Agents and Chemotherapy.

[6]  James R. Brown,et al.  Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.

[7]  J. Gut,et al.  Screening of Protease Inhibitors as Antiplasmodial Agents. Part I: Aziridines and Epoxides , 2007, ChemMedChem.

[8]  A. Chishti,et al.  Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents. , 2006, Journal of medicinal chemistry.

[9]  Ashutosh Kumar Singh,et al.  Characterization of Native and Recombinant Falcipain-2, a Principal Trophozoite Cysteine Protease and Essential Hemoglobinase ofPlasmodium falciparum * , 2000, The Journal of Biological Chemistry.

[10]  Markus Hardt,et al.  Hemoglobin Cleavage Site-Specificity of the Plasmodium falciparum Cysteine Proteases Falcipain-2 and Falcipain-3 , 2009, PloS one.

[11]  S. Kappe,et al.  Malaria: progress, perils, and prospects for eradication. , 2008, The Journal of clinical investigation.

[12]  Kelly Chibale,et al.  Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. , 2003, Bioorganic & medicinal chemistry letters.

[13]  Jiri Gut,et al.  Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. , 2004, Journal of medicinal chemistry.

[14]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[15]  T. Schirmeister,et al.  Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors. , 2011, European journal of medicinal chemistry.

[16]  J T Palmer,et al.  Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors , 1996, Antimicrobial agents and chemotherapy.

[17]  Maria A. Miteva,et al.  Hierarchical Structure-Based Virtual Screening for Drug Design , 2008 .

[18]  M. Zappalà,et al.  Falcipain‐2 inhibitors , 2010, Medicinal research reviews.

[19]  R. Ménard,et al.  Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases. , 1995, Journal of medicinal chemistry.

[20]  Ismael Zamora,et al.  Suitability of GRIND-Based Principal Properties for the Description of Molecular Similarity and Ligand-Based Virtual Screening , 2009, J. Chem. Inf. Model..

[21]  Tao Wu,et al.  Road towards new antimalarials - overview of the strategies and their chemical progress. , 2011, Current medicinal chemistry.

[22]  Ashutosh Kumar Singh,et al.  Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. , 2001, The Biochemical journal.

[23]  Juan Miguel,et al.  Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series. , 2010, Journal of medicinal chemistry.

[24]  S. Ekins,et al.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling , 2007, British journal of pharmacology.

[25]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[26]  J. E. Hyde,et al.  Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. , 2002, Microbes and infection.

[27]  J. Dalton,et al.  Cysteine Proteases of Pathogenic Organisms , 2011 .

[28]  P. Rosenthal,et al.  Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease. , 1997, Journal of medicinal chemistry.

[29]  S. Ralph,et al.  Protein translation in Plasmodium parasites. , 2011, Trends in parasitology.

[30]  Linda S. Brinen,et al.  Structures of Falcipain-2 and Falcipain-3 Bound to Small Molecule Inhibitors: Implications for Substrate Specificity‡ , 2009, Journal of medicinal chemistry.

[31]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[32]  J T Palmer,et al.  Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. , 1991, The Journal of clinical investigation.

[33]  Woody Sherman,et al.  Computer-Aided Drug Design of Falcipain Inhibitors: Virtual Screening, Structure-Activity Relationships, Hydration Site Thermodynamics, and Reactivity Analysis , 2012, J. Chem. Inf. Model..

[34]  P. Rosenthal.  Falcipains and other cysteine proteases of malaria parasites. , 2011, Advances in experimental medicine and biology.

[35]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[36]  M. Leippe,et al.  Novel peptidomimetics containing a vinyl ester moiety as highly potent and selective falcipain-2 inhibitors. , 2009, Journal of medicinal chemistry.

[37]  Jiri Gut,et al.  Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. , 2006, Journal of medicinal chemistry.

[38]  J. Gomes,et al.  Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria. , 2011, Current medicinal chemistry.

[39]  Julie Clark,et al.  Discovery of Novel Antimalarial Compounds Enabled by QSAR-Based Virtual Screening , 2013, J. Chem. Inf. Model..

[40]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[41]  Robert G. Ridley,et al.  Medical need, scientific opportunity and the drive for antimalarial drugs , 2002, Nature.

[42]  R. Pink,et al.  Opportunities and Challenges in Antiparasitic Drug Discovery , 2005, Nature Reviews Drug Discovery.

[43]  W. Ballou.  The development of the RTS,S malaria vaccine candidate: challenges and lessons , 2009, Parasite immunology.

[44]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[45]  F E Cohen,et al.  Structure-based inhibitor design by using protein models for the development of antiparasitic agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[47]  J. Gut,et al.  Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors. , 2008, Bioorganic & medicinal chemistry letters.